Lensar (LNSR) EPS (Diluted) (QoQ) (2021 - 2026)
Lensar (LNSR) EPS (Diluted) (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Lensar | 102.19 Mn | 88.62 Mn | 9.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -99.60% |
| Mar 31, 2026 | 1,106.00% |
| Dec 31, 2025 | 60.45% |
| Sep 30, 2025 | -108.62% |
| Jun 30, 2025 | 93.64% |
| Mar 31, 2025 | -43.04% |
| Dec 31, 2024 | -1,154.44% |
| Sep 30, 2024 | 83.61% |
| Jun 30, 2024 | -316.90% |
| Mar 31, 2024 | 47.07% |
| Dec 31, 2023 | -398.57% |
| Sep 30, 2023 | 114.82% |
| Jun 30, 2023 | -102.92% |
| Mar 31, 2023 | -62.65% |
| Dec 31, 2022 | 37.20% |
| Sep 30, 2022 | 41.83% |
| Jun 30, 2022 | -0.21% |
| Mar 31, 2022 | -60.86% |
| Dec 31, 2021 | 36.16% |
| Sep 30, 2021 | -38.97% |